China Resources Double-Crane Stock Hits Day Low Amid Price Pressure at CNY 16.00

China Resources Double-Crane Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock hitting an intraday low of CNY 16.00, reflecting a decrease of 3.78% for the day. This performance is part of a broader trend, as the company has seen a 3.49% drop over the past week and a 4.18% decline over the past month. In the context of the larger market, the China Shanghai Composite index has shown a contrasting performance, gaining 0.5% today. Over the past year, China Resources Double-Crane has underperformed significantly, with a return of -14.04%, while the Shanghai Composite has risen by 18.87%. Key financial metrics indicate that the company has faced challenges, with net sales growing at an annual rate of only 5.57% over the last five years. The operating cash flow has reached a low of CNY 1,632.37 million, and the interest coverage ratio is at its lowest point. Despite a relatively attractive valuation with a price-to-book ratio of 1.76 and a dividend yield of 2.5%, the stock's performance has been below par in both the short and long term.